- Originating issuer
- Novartis
- Last review date
- 2026-10-12
Novartis describes an innovative medicines business. This is an institutional profile, not a medicine advertisement or a statement of Kenyan product availability.
Scope of this source
Editorial information profile. No paid relationship, endorsement or product approval is implied. Specific services, funding eligibility and announcements require their own current source.
How this record is used
This source record connects the original document to reporting on Health Signal. The review covers the identity of the issuing source, the date shown on the record and the relationship between the linked document and the article. A source check is not independent replication of research, an audit of public expenditure or endorsement of a product. Later developments require a later source and a dated update.